Insider Trading Alert - LDRH, XNCR And NRIM Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Friday, June 12, 2015, 76 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $100.00 to $5,841,705.00.

Highlighted Stocks Traded by Insiders:

LDR (LDRH) - FREE Research Report

Lavigne Christophe, who is President & CEO at LDR, sold 20,000 shares at $44.55 on June 12, 2015. Following this transaction, the President & CEO owned 661,589 shares meaning that the stake was reduced by 2.93% with the 20,000-share transaction.

The shares most recently traded at $43.91, down $0.64, or 1.45% since the insider transaction. Historical insider transactions for LDR go as follows:

  • 4-Week # shares bought: 110,000
  • 4-Week # shares sold: 101,200
  • 12-Week # shares bought: 110,000
  • 12-Week # shares sold: 175,038
  • 24-Week # shares bought: 110,000
  • 24-Week # shares sold: 736,982

The average volume for LDR has been 227,900 shares per day over the past 30 days. LDR has a market cap of $1.2 billion and is part of the health care sector and health services industry. Shares are up 35.97% year-to-date as of the close of trading on Friday.

LDR Holding Corporation, a medical device company, focuses on designing and commercializing various surgical technologies for the treatment of patients suffering from spine disorders in the United States and internationally. Currently, there are 6 analysts who rate LDR a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on LDRH - FREE

TheStreet Quant Ratings rates LDR as a sell. Among the areas we feel are negative, one of the most important has been weak operating cash flow. Get the full LDR Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Xencor (XNCR) - FREE Research Report

Kuch John J, who is Vice President, Finance at Xencor, sold 8,756 shares at $19.35 on June 12, 2015. Following this transaction, the Vice President, Finance owned 10,650 shares meaning that the stake was reduced by 45.12% with the 8,756-share transaction.

The shares most recently traded at $19.18, down $0.17, or 0.88% since the insider transaction. Historical insider transactions for Xencor go as follows:

  • 4-Week # shares sold: 20,000
  • 12-Week # shares sold: 22,204
  • 24-Week # shares sold: 22,204

The average volume for Xencor has been 200,900 shares per day over the past 30 days. Xencor has a market cap of $783.8 million and is part of the health care sector and drugs industry. Shares are up 21.07% year-to-date as of the close of trading on Friday.

Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. Currently, there are 3 analysts who rate Xencor a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on XNCR - FREE

TheStreet Quant Ratings rates Xencor as a hold. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share and deteriorating net income. Get the full Xencor Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Northrim BanCorp (NRIM) - FREE Research Report

Nelson Murphy Krystal, who is Director at Northrim BanCorp, bought 50 shares at $26.81 on June 12, 2015. Following this transaction, the Director owned 50 shares meaning that the stake was boosted by 100% with the 50-share transaction.

The shares most recently traded at $27.00, up $0.19, or 0.7% since the insider transaction. Historical insider transactions for Northrim BanCorp go as follows:

  • 4-Week # shares bought: 6,312
  • 4-Week # shares sold: 2,800
  • 12-Week # shares bought: 6,312
  • 12-Week # shares sold: 2,800
  • 24-Week # shares bought: 9,117
  • 24-Week # shares sold: 2,800

The average volume for Northrim BanCorp has been 20,400 shares per day over the past 30 days. Northrim BanCorp has a market cap of $183.8 million and is part of the financial sector and banking industry. Shares are up 4.15% year-to-date as of the close of trading on Friday.

Northrim BanCorp, Inc. operates as bank holding company for Northrim Bank that provides commercial banking products and services to businesses and professional individuals primarily in Alaska. The company operates in two segments, Community Banking and Home Mortgage Lending. The stock currently has a dividend yield of 2.69%. The company has a P/E ratio of 10.1. Currently, there is 1 analyst who rates Northrim BanCorp a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NRIM - FREE

TheStreet Quant Ratings rates Northrim BanCorp as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, compelling growth in net income, notable return on equity and impressive record of earnings per share growth. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full Northrim BanCorp Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Dow Falls, S&P 500 Trades Lower as P&G and Apple Slump

Dow Falls, S&P 500 Trades Lower as P&G and Apple Slump

Video: Jim Cramer on Apple, Procter & Gamble, Nucor and Acacia Communications

Video: Jim Cramer on Apple, Procter & Gamble, Nucor and Acacia Communications

Video: Jim Cramer Reveals Why Stocks Are Moving Lower Thursday

Video: Jim Cramer Reveals Why Stocks Are Moving Lower Thursday

Soaring Nickel Prices Could Be Bad News for Electric Carmakers Like Tesla

Soaring Nickel Prices Could Be Bad News for Electric Carmakers Like Tesla

Video: The Road to S&P 500 2,800 Is 'Slow and Choppy'

Video: The Road to S&P 500 2,800 Is 'Slow and Choppy'